Angiodynamics Inc (ANGO) Stock Price & Analysis
Angiodynamics Inc (ANGO) fell 0.40% to USD 15.14 as of September 8, 2026 at 15:25 UTC, according to Nexqual real-time market data.
ANGO last closed at USD 15.14; the session ranged USD 15.03–15.36 on volume of 61,500 shares. Market capitalization is —, with a 52-week range of USD 9.39–16.29 (NMS). Source: Nexqual, September 8, 2026 at 15:25 UTC.
Key Statistics (as of September 8, 2026 at 15:25 UTC)
| Price | USD 15.14 |
|---|---|
| Change | ▼ 0.40% (down) |
| Previous Close | USD 15.14 |
| Open | USD 15.14 |
| Day Range | USD 15.03 – 15.36 |
| 52-Week Range | USD 9.39 – 16.29 |
| Volume | 61,500 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ANGO)
Nexqual's technical model rates ANGO "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 15:25 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.57 (neutral) |
| vs SMA50 | Above (USD 14.65) |
| MACD | 0.2 (positive) |
From Angiodynamics Inc's Latest SEC 10-K Filing (filed 2026-07-14)
Key Strengths & Strategy (as disclosed to the SEC)
- Thrombectomy Our Thrombus Management portfolio includes the AlphaVac Mechanical Thrombectomy System, AngioVac venous drainage cannula and circuit, as well as catheter directed thrombolytic devices, including the Uni-Fuse system and the Uni-Fuse+ system.
- AngioDynamics' Uni-Fuse infusion catheter features pressure response outlets, a proprietary slit technology that provides a consistent, even distribution of fluid volume along the entire length of the infusion pattern, designed to provide an advantage over standard side-hole catheters. 4 NanoKnife The NanoKnife IRE Ablation System is an alternative to traditional thermal ablation that received 510(k) clearance from the Food and Drug Administration for the surgical ablation of soft tissue.
- In December 2024, the NanoKnife System received expanded FDA 510(k) clearance for the ablation of prostate tissue which broadens treatment options for men and reinforces the system's strong safety and efficacy profile.
- The Solero MTA System and Accessories are indicated for the ablation of soft tissue during open procedures by the FDA in the USA and for open laparoscopic and percutaneous procedures under the European MDR regulations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATRC | AtriCure, Inc. | USD 52.07 | ▼ 0.75% |
| CNMD | CONMED Corporation | USD 46.32 | ▼ 6.27% |
| MMSI | Merit Medical Systems, Inc. | USD 87.32 | ▼ 1.41% |
| OFIX | Orthofix Medical Inc. | USD 8.98 | ▼ 3.54% |
| ICUI | ICU Medical, Inc. | USD 161.71 | ▼ 2.75% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:25 UTC. This page is informational and not investment advice.